PAPR-2 is another significantly different gene, and studies have shown that the DNA damage/PARP-1 signalling pathway is important for the development of PAH, but the relevance of PAPR-2 to PAH has not been confirmed [37]. This evidence concerns the gene PARP1 and pulmonary arterial hypertension.